Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P Fenaux

Lenalidomide With or Without Erythropoietin in Transfusion-Dependent Erythropoiesis-Stimulating Agent-Refractory Lower-Risk MDS Without 5q Deletion

Leukemia

English

Long-Term Outcome of Anemic Lower-Risk Myelodysplastic Syndromes Without 5q Deletion Refractory to or Relapsing After Erythropoiesis-Stimulating Agents

English

Cooperation of Activating Ras/RTK Signal Transduction Pathway Mutations and Inactivating Myeloid Differentiation Gene Mutations in M0 AML: A Study of 45 Patients

English

Phase I Study of Cinchonine, a Multidrug Resistance Reversing Agent, Combined With the CHVP Regimen in Relapsed and Refractory Lymphoproliferative Syndromes

English

Detection of BCR-ABL Transcripts in Chronic Myeloid Leukemia (CML) Using a ‘Real Time’ Quantitative RT-PCR Assay

English

Is There a Role for All-Trans Retinoic Acid in Combination With Recombinant Erythropoetin in Myelodysplastic Syndromes? A Report on 59 Cases

English

Classification of Myeloproliferative Disorders in the JAK2 Era: Is There a Role for Red Cell Mass?

English

Acute Myeloblastic Leukemia (AML) With Inv (16)(p13;q22) and the Rare I Type CBFβ-MYH11 Transcript: Report of Two New Cases

English

Role of Splenectomy in the Treatment of Myelodysplastic Syndromes With Peripheral Thrombocytopenia: A Report on Six Cases

English

Inhibition of NEMO, the Regulatory Subunit of the IKK Complex, Induces Apoptosis in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P Fenaux

Lenalidomide With or Without Erythropoietin in Transfusion-Dependent Erythropoiesis-Stimulating Agent-Refractory Lower-Risk MDS Without 5q Deletion

Long-Term Outcome of Anemic Lower-Risk Myelodysplastic Syndromes Without 5q Deletion Refractory to or Relapsing After Erythropoiesis-Stimulating Agents

Cooperation of Activating Ras/RTK Signal Transduction Pathway Mutations and Inactivating Myeloid Differentiation Gene Mutations in M0 AML: A Study of 45 Patients

Phase I Study of Cinchonine, a Multidrug Resistance Reversing Agent, Combined With the CHVP Regimen in Relapsed and Refractory Lymphoproliferative Syndromes

Detection of BCR-ABL Transcripts in Chronic Myeloid Leukemia (CML) Using a ‘Real Time’ Quantitative RT-PCR Assay

Is There a Role for All-Trans Retinoic Acid in Combination With Recombinant Erythropoetin in Myelodysplastic Syndromes? A Report on 59 Cases

Classification of Myeloproliferative Disorders in the JAK2 Era: Is There a Role for Red Cell Mass?

Acute Myeloblastic Leukemia (AML) With Inv (16)(p13;q22) and the Rare I Type CBFβ-MYH11 Transcript: Report of Two New Cases

Role of Splenectomy in the Treatment of Myelodysplastic Syndromes With Peripheral Thrombocytopenia: A Report on Six Cases

Inhibition of NEMO, the Regulatory Subunit of the IKK Complex, Induces Apoptosis in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia